Incidence and risk of chondrolysis in Denmark: A nationwide population-based study by Christiansen, Christian F et al.
© 2010 Christiansen et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Clinical Epidemiology 2010:2 85–89
Clinical Epidemiology
Incidence and risk of chondrolysis in Denmark:  
A nationwide population-based study
Christian F Christiansen  
Sandra K Thygesen  
Lars Pedersen
Department of Clinical Epidemiology, 
Aarhus University Hospital, Aarhus, 
Denmark
Correspondence: Christian F Christiansen 
Epidemiology, Aarhus University Hospital, 
Olof Palmes Alle 43–45, DK-8200  
Aarhus C, Denmark
Tel +45 89 424 800
Fax +45 89 424 801
Email cc@dce.au.dk
Background: Chondrolysis is a rare disease with destruction of cartilage of joints. Incidence 
and risk factors have not been studied in a formal epidemiologic population-based setting.
Methods: We used the Danish National Registry of Patients (NRP) covering all Danish hospitals 
to identify all cases of chondrolysis from 1994 to 2008. Incidence rates were estimated using the 
general population as the denominator. For each chondrolysis patient, 10 age-matched population 
controls were sampled for a case-control analysis. For cases and controls, we ascertained in the 
NRP history of diabetes, rheumatoid arthritis, orthopedic surgery, including surgery of shoulder and 
upper arm, injury to shoulder girdle or upper arm, and treatment with pain pump. We determined 
the prevalence of these risk factors in cases and controls, and computed odds ratios (OR).
Results: We identified 43 patients with chondrolysis in the 15-year study period. The incidence 
rate was 5.5 per 10,000,000 person-years. Diabetes was more prevalent in chondrolysis cases, 
compared with the 430 controls (OR = 6.7; 95% confidence intervals [CI]: 1.1–39.9). Ortho-
pedic surgery was also associated with an increased risk of chondrolysis (OR = 28.8, 95% CI: 
11.0–75.6), while previous injury was not (OR = 0.8; 95% CI: 0.1–5.9).
Conclusion: Chondrolysis was rarely diagnosed in Denmark. Diabetes and orthopedic surgery 
may be risk factors.
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Introduction
Chondrolysis is a rare disease characterized by destruction of cartilage of joints such 
as hip, knee, ankle, or shoulder.1 The relevant literature is virtually restricted to case 
reports and case series.1 Chondrolysis has been reported among adolescent females 
after slipped capital femoral epiphysis.2 Other suggested risk factors include trauma, 
infections, and prolonged immobilization.1
Chondrolysis of the shoulder (glenohumeral chondrolysis) has been reported most 
frequently among young men.3 Recently, a case series described glenohumeral chon-
drolysis after shoulder arthroscopy,4 in two and eight cases after arthroscopic thermal 
capsuorrhaphy,5,6 and in two patients after color tests using gentian violet in two cases 
after a color test.7 Use of intra-articular pain pump infusing bupivacaine has also been 
associated with glenohumeral chondrolysis8 in case series including 12 cases9 and 
23 cases,10 and in one case with bilateral shoulder arthroscopy in which chondrolysis 
developed at the side of pain catheter.11
Incidence and risk factors for chondrolysis have not been assessed in a population-
based setting in a formal epidemiological study. Such data could help us to understand 
and potentially prevent this rare, but serious, disease.
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We conducted a population-based case-control study to 
estimate the incidence of chondrolysis, and explore potential 
risk factors.
Methods
We conducted this population-based case-control study in 
Denmark (population ∼ 5.4 million). The Danish National 
Health Service provides free tax-funded medical care for 
all Danish residents. The unique civil registration number 
assigned to every Danish citizen enabled electronic linkage 
of several medical databases.12 The study was approved 
by the Central Denmark Region on behalf of the Danish 
Data Protection Agency and by the Aarhus University 
Registry Board.
Cases with chondrolysis
We identified all cases of chondrolysis recorded during 
the 15-year period between January 1, 1994 and December 
31, 2008 in the Danish NRP.13 The NRP has tracked all 
discharges from all somatic hospitals since 1977, including, 
since 1995, emergency room and outpatient clinic visits. 
Each record contains variables for patients’ civil registra-
tion numbers, dates of admission and discharge, surgical 
procedures, treatments, and up to 20 diagnoses, coded 
by physicians according to the International Classifica-
tion of Diseases (ICD) (8th edition until the end of 1993, 
10th edition thereafter). The ICD-10 code used to identify 
cases of chondrolysis was M94.3. In order to estimate 
the validity of the NRP diagnoses, we reviewed medi-
cal records of patients in Northern Jutland (population ∼ 
0.6 million).14–16
Population controls
From the Danish Civil Registration System (CRS),12 we 
selected 10 age-matched population controls for each 
chondrolysis case. Controls were sampled using risk-set 
sampling from among the Danes who were alive on the date 
an index chondrolysis case was diagnosed (the index date). 
The CRS, which was established in 1968, is updated daily 
and contains data on civil registration number, residence, 
migration, vital status (dead or alive), and date of death for 
all Danish residents.
Potential risk factors
From the NRP, we obtained data on any history (until the 
index date) of orthopedic surgery or surgery of the shoulder 
or upper limb which has been recorded since 1989, data on 
any history of injuries to the upper arm or shoulder girdle for 
up to 20 years before the index date (the diagnostic codes are 
provided in the Appendix), and data on history of diabetes or 
rheumatoid arthritis for up to 20 years before index date. We 
also included NRP records of pain pump treatment, which 
has been recorded since 1999. Because the data quality of 
this code is unknown, we selected for medical record review 
patients registered with pain pump treatment at one of the 
university hospitals.
Statistical analyses
The incidence of chondrolysis was computed in 10-year age 
groups. Incidence rates were estimated using the general 
population as a denominator, using the corresponding age 
group listed in the official reports by Statistics Denmark.17
The prevalence of risk factors was described for cases and 
controls. Unadjusted odds ratios (ORs) were computed by con-
ditional logistic regression for potential risk factors comparing 
chondrolysis cases with age-matched controls. Using risk-set 
sampling for control selection renders the OR interpretable as 
an estimate of the corresponding rate ratio (RR).
Statistical analyses were performed with SAS software 
(version 9.1; SAS Institute, Cary, NC).
Results
We identified 43 patients diagnosed with chondrolysis 
in the study period; 32 (74.4%) were aged 20–49 years, 
and 22 (51.2%) were males (Table 1). Twenty patients 
were diagnosed in 1994–1999 and 23 were diagnosed in 
2000–2008.
The incidence rate (IR) of chondrolysis in the Danish 
population was 5.5 per 10,000,000 person-years, and it 
was the highest in persons aged 40–49 years (IR = 11.9 per 
10,000,000 person-years) (Table 2).
Two (4.7%) of the 43 chondrolysis cases had a history 
of diabetes compared with 3 (0.7%) of the 430 population 
controls, corresponding to an OR of 6.7 (95% confidence 
intervals [CI]: 1.1–39.9). A history of rheumatoid arthritis 
was recorded for one chondrolysis case and one control (OR = 
10.0; 95% CI: 0.6–159.9) (Tables 1 and 3). One chondrolysis 
case (2.3%) and 13 (3.0%) controls had a history of upper 
arm and shoulder girdle (OR = 0.8; 95% CI: 0.1–5.9). A 
history of orthopedic procedure was recorded in a majority 
of the chondrolysis patients (74.4%), but was less common 
among the controls (13.5%), corresponding to an OR of 28.8 
(95% CI: 11.0–75.6). Likewise, cases were more likely than 
controls to have undergone a surgery of shoulder and upper 
arm (7.0% vs 3.5%; OR = 2.1, 95% CI: 0.6–7.8). No cases 
or controls were coded with pain pump treatment.
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Medical record review
Five patients with chondrolysis in the Northern Jutland were 
identified in the NRP, but only four medical records were 
available and reviewed. All four medical record had described 
cartilage lesion, but there we no specific details. The positive 
predictive value (PPV) of the recorded diagnosis would be 
100% (97.5% one-sided CI: 48%–100%) assuming the missing 
record had a confirmed cartilage lesion and PPV would be 80% 
(95% CI: 28%–99%), if missing record were not confirmed.
From the NRP, we identified all 46 patients with a 
pain pump code since 1999 at one university hospital. The 
medical record contained notes of pain pump coding for 
23 of the patients. An additional four patients had a note in 
the medical record on the date of pain pump treatment, but 
this treatment was not described in the text. The remaining 
19 patients did not have a description of the pump in the 
surgical record, but some of these may most likely have 
been treated with pain pump by anesthesiologists, who 
had recorded it on separate observation sheets that were 
available in the surgical record. The PPV of pain pump 
treatment was thus 50% (95% CI: 35%–65%) or 91% (95% 
CI: 79%–98%), depending on whether patients without a 
note in the medical record actually underwent pain pump 
treatment.
Discussion
This is the first study that addressed the basic epidemiology 
of chondrolysis in a population-based setting. A diagnosis 
of chondrolysis in Denmark was rare. Most patients were 
aged 20–49 years, with nearly equal proportions of males 
and females. A history of orthopedic surgery or diabetes was 
associated with an increased risk of chondrolysis.
Our study extends previous reports of chondrolysis after 
orthopedic surgery, including shoulder surgery.2,4,6,9,11,18 In 
contrast to previous reports, we found the highest rate of 
chondrolysis in middle-aged women and men. The finding 
regarding diabetes was surprising.
This study had the strength of a population-based design 
within a free tax-supported health care system reducing 
selection and referral bias, but there were several limita-
tions. Chondrolysis is not a clinical well-defined disease 
and it is most likely that it is under-recorded in the hospital 
registry particularly in milder cases; therefore our incidence 
estimates are most likely conservative. Misclassification of 
risk factors is most likely nondifferential as these data are 
obtained independently on outcome and may bias our esti-
mates towards unity.
Table 2 Incidence of a hospital diagnosis of chondrolysis in the 
Danish population
Hospital  
diagnosis of 
chondrolysis 
1994–2008 (N)
Danish 
population  
on January 1, 
1994
Incidence rates 
per 10,000,000 
person-years
Age group
10–19 years 2 619,998 2.15
20–29 years 10 791,046 8.43
30–39 years 8 759,894 7.02
40–49 years 14 785,348 11.88
50–59 years 6 592,627 6.75
60–69 years 0 467,229 0.00
70–79 years 1 369,445 1.80
80–89 years 2 176,927 7.54
Table 3 Odds ratios (Or) of chondrolysis in patients with risk 
factors compared with those without this risk factor
OR (95% CI)
Male sex 1.1 (0.6–2.1)
History of diabetes 6.7 (1.1–39.9)
History of rheumatoid arthritis 10.0 (0.6–159.9)
History of injury involving the upper  
arm and shoulder girdle
0.8 (0.1–5.9)
History of any orthopedic surgery 28.8 (11.0–75.6)
History of surgery of shoulder or upper arm 2.1 (0.6–7.8)
Abbreviation: CI, confidence interval.
Table 1 Characteristics of chondrolysis cases and population 
controls
Chondrolysis  
cases (n = 43)
Population  
controls  
(n = 430)
n % n %
Age group, years
10–19 2 4.7 20 4.7
20–29 10 23.3 100 23.3
30–39 8 18.6 80 18.6
40–49 14 32.6 140 32.6
50–59 6 14.0 60 14.0
60–69 0 0.0 0 0.0
70–79 1 2.3 10 2.3
80–89 2 4.7 20 4.7
Sex
Female 21 48.8 223 51.9
Male 22 51.2 207 48.1
Diabetes 2 4.7 3 0.7
Rheumatoid arthritis 1 2.3 1 0.2
Injury involving the  
upper arm and  
shoulder girdle
1 2.3 13 3.0
A history of orthopedic  
surgery
32 74.4 58 13.5
A history of surgery of  
shoulder or upper arm
3 7.0 15 3.5
Pain pump treatment 0 0.0 0 0.0
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Because no code for chondrolysis existed in the ICD-8 
used in Denmark before 1994, prevalent cases could not be 
excluded from our sample. Our case series may therefore be 
a mixture of incident and prevalent cases, which may explain 
a slightly higher annual number of cases in 1994–1999 
compared with 2000–2008. Still, the difference in these time 
periods is small and unlikely to explain away the observation 
that chondrolysis patients in our study were older compared 
with previous reports.
NRP data on diabetes hospitalization is known to be valid, 
however, we may only have included the most severe cases of 
diabetes as patients with milder type 2 diabetes may be treated 
by general practitioner only and would therefore not appear 
in the registry.19,20 Surgical procedures are registered in the 
NRP with high validity.21 The completeness of registration of 
pain pump treatment is unknown; the medical record review 
showed that a majority of the patients with notes at time of 
treatment actually had pain pump treatment. We had no data 
on localization of chondrolysis, which may explain the lower 
association between chrondolysis and surgery of shoulder and 
upper arm compared with any orthopedic surgery.
In conclusion, chondrolysis was rarely diagnosed in 
  Denmark. Our data suggest that diabetes and orthopedic 
surgery may be risk factors.
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Appendix
Codes for diagnoses, treatments,  
and surgery
History up to 20 years prior to index date of:
Diabetes mellitus
ICD-8: 249–250
ICD-10: E10–E14, O24 (except O24.4), H36.0
Rheumatoid arthritis
ICD-8: 712
ICD-10: M05, M06, M08, M09
Pain treatment using pain pump
(BAFA88) (available 1999–)
Surgical procedures involving the shoulder or upper 
arm
After 1996: [(K)NB]
1.jan1989–31.dec.1995: 7xx00, 7xx01, 7xx02, 7xx03, 7xx04, 
7xx05, 7xx06, 7xx07, 7xx08, 7xx09.
Injuries involving the upper arm and shoulder girdle
ICD-8: 810–812, 831, 840, 849.00, 849.01, 849.08, 849.09, 
880, 887.02, 902.00, 902.01, 902.10, 902.11, 905, 912.99, 
923.99, 952.
ICD-10: S40–S49
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
89
Chondrolysis in Denmark